| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.077 | 0.8 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |